Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Romito

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Anti-Cancer Drugs|March 1, 1997
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology GroupG Colucci, F Giotta, V Gebbia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)E Maiello, F Giuliani, V Gebbia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2006
Anti-GD2-like IgM autoreactivity in multiple sclerosis patientsS Marconi, M Acler, L Lovato, et al.
British Journal of Cancer|November 1, 1995
Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM)G Colucci, S Romito, V Gebbia, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Sequential treatment with high-dose methotrexate and fluorouracil in advanced colorectal cancer. Experience of the Southern Italian Oncology Group (GOIM)G Colucci, E Maiello, A Pedicini, et al.
Acta Neurologica Scandinavica|May 18, 2013
No evidence of cardiomyopathy in spinal and bulbar muscular atrophyG Querin, P Melacini, C D'Ascenzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM)E Maiello, V Gebbia, F Giuliani, et al.
Brain & Spine|October 17, 2022
Degenerative cervical myelopathy: Neuroradiological, neurophysiological and clinical correlations in 27 consecutive casesC Soda, G Squintani, M Teli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2007
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)F De Vita, F Giuliani, M Orditura, et al.
European Journal of Cancer Care|August 17, 2013
Patients attitudes towards sleep disturbances during chemotherapyF Romito, C Cormio, S De Padova, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Anti-Cancer Drugs|March 1, 1997
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology GroupG Colucci, F Giotta, V Gebbia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)E Maiello, F Giuliani, V Gebbia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2006
Anti-GD2-like IgM autoreactivity in multiple sclerosis patientsS Marconi, M Acler, L Lovato, et al.
British Journal of Cancer|November 1, 1995
Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM)G Colucci, S Romito, V Gebbia, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Sequential treatment with high-dose methotrexate and fluorouracil in advanced colorectal cancer. Experience of the Southern Italian Oncology Group (GOIM)G Colucci, E Maiello, A Pedicini, et al.
Acta Neurologica Scandinavica|May 18, 2013
No evidence of cardiomyopathy in spinal and bulbar muscular atrophyG Querin, P Melacini, C D'Ascenzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM)E Maiello, V Gebbia, F Giuliani, et al.
Brain & Spine|October 17, 2022
Degenerative cervical myelopathy: Neuroradiological, neurophysiological and clinical correlations in 27 consecutive casesC Soda, G Squintani, M Teli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2007
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)F De Vita, F Giuliani, M Orditura, et al.
European Journal of Cancer Care|August 17, 2013
Patients attitudes towards sleep disturbances during chemotherapyF Romito, C Cormio, S De Padova, et al.
Pageof 3